The global in-vitro fertilization (IVF) market, valued at over $26.5 billion in 2023 and projected by some analysts to exceed $35 billion by 2030, is at the point of a technological revolution.
New York-based Conceivable Life Sciences is positioning itself at the vanguard of this transformation, developing what it claims is the world’s first end-to-end automated, AI-powered IVF laboratory.
This innovation promises to not only disrupt existing methodologies but also significantly expand market reach by tackling critical barriers of cost, accessibility, and scalability. [Read more…] about Robotic IVF: Conceivable Life Sciences targets $35 billion market with automated labs
